BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36589281)

  • 1. Oncohistones: Hijacking the histone code.
    Sahu V; Lu C
    Annu Rev Cancer Biol; 2022 Apr; 6():293-312. PubMed ID: 36589281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone H3K27M Mutation in Brain Tumors.
    El-Hashash AHK
    Adv Exp Med Biol; 2021; 1283():43-52. PubMed ID: 33155136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone H3 Mutations in Cancer.
    Wan YCE; Liu J; Chan KM
    Curr Pharmacol Rep; 2018; 4(4):292-300. PubMed ID: 30101054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H2B Mutations in Cancer.
    Wan YCE; Chan KM
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34205231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
    Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
    Elife; 2020 Sep; 9():. PubMed ID: 32902381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cancer: Oncohistones in action.
    Qiu L; Hu X; Jing Q; Zeng X; Chan KM; Han J
    J Genet Genomics; 2018 May; 45(5):227-236. PubMed ID: 29804713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dark side of histones: genomic organization and role of oncohistones in cancer.
    Amatori S; Tavolaro S; Gambardella S; Fanelli M
    Clin Epigenetics; 2021 Apr; 13(1):71. PubMed ID: 33827674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone mutations in cancer.
    Espinoza Pereira KN; Shan J; Licht JD; Bennett RL
    Biochem Soc Trans; 2023 Oct; 51(5):1749-1763. PubMed ID: 37721138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Function of Oncohistones Using Mutant Transgenes and Knock-In Mutations.
    Fang D; Wang H; Zhang Z
    Methods Mol Biol; 2018; 1832():339-356. PubMed ID: 30073537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncohistones: a roadmap to stalled development.
    Deshmukh S; Ptack A; Krug B; Jabado N
    FEBS J; 2022 Mar; 289(5):1315-1328. PubMed ID: 33969633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Molecular Underpinnings of Cancer-Causing Oncohistone Mutants Using Yeast as a Model.
    Zhang X; Fawwal DV; Spangle JM; Corbett AH; Jones CY
    J Fungi (Basel); 2023 Dec; 9(12):. PubMed ID: 38132788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Saccharomyces cerevisiae model and screen to define the functional consequences of oncogenic histone missense mutations.
    Lemon LD; Kannan S; Mo KW; Adams M; Choi HG; Gulka AOD; Withers ES; Nurelegne HT; Gomez V; Ambrocio RE; Tumminkatti R; Lee RS; Wan M; Fasken MB; Spangle JM; Corbett AH
    G3 (Bethesda); 2022 Jul; 12(7):. PubMed ID: 35567477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
    Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncohistones in brain tumors: the soil and seed.
    Andrade AF; Chen CCL; Jabado N
    Trends Cancer; 2023 May; 9(5):444-455. PubMed ID: 36933956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone isoforms and the oncohistone code.
    Flaus A; Downs JA; Owen-Hughes T
    Curr Opin Genet Dev; 2021 Apr; 67():61-66. PubMed ID: 33285512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncohistones: drivers of pediatric cancers.
    Mohammad F; Helin K
    Genes Dev; 2017 Dec; 31(23-24):2313-2324. PubMed ID: 29352018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Mutations and Bone Cancers.
    Taylor EL; Westendorf JJ
    Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.
    Jayaram H; Hoelper D; Jain SU; Cantone N; Lundgren SM; Poy F; Allis CD; Cummings R; Bellon S; Lewis PW
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6182-7. PubMed ID: 27185940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.
    Panwalkar P; Tamrazi B; Dang D; Chung C; Sweha S; Natarajan SK; Pun M; Bayliss J; Ogrodzinski MP; Pratt D; Mullan B; Hawes D; Yang F; Lu C; Sabari BR; Achreja A; Heon J; Animasahun O; Cieslik M; Dunham C; Yip S; Hukin J; Phillips JJ; Bornhorst M; Griesinger AM; Donson AM; Foreman NK; Garton HJL; Heth J; Muraszko K; Nazarian J; Koschmann C; Jiang L; Filbin MG; Nagrath D; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Allis CD; Chinnaiyan AM; Lunt SY; Blüml S; Judkins AR; Venneti S
    Sci Transl Med; 2021 Oct; 13(614):eabc0497. PubMed ID: 34613815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding landscape of 'oncohistone' mutations in human cancers.
    Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
    Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.